In macrophages, which play a pivotal role in COPD by producing inflammatory cytokines and ROS, the differential expression of Nrf2 indicates that certain subsets may be more effective in activating antioxidant responses, thereby reducing oxidative damage and inflammation. Here, NFE2L2 is linked to chronic obstructive pulmonary disease.